autoimmune

Infliximab was the first antibody for IBD. Biointron reviews its approval, mechanism, and impact on advancing therapeutic monoclonal antibodies.

Autoimmune diseases demand precision therapy. Biointron explains how antibody drugs target RA, MS, and other conditions to reduce inflammation and improve outcomes.

DOI:10.1126/science.adg0564 B cells, or B lymphocytes, are a crucial component of the adaptive immune system andhumoral immunity. They originate from the bone marrow and mature in secondary lymphoid organs, such as the spleen and lymph nodes. The B ce

Bispecific antibodies are transforming medicine. Biointron highlights their design, therapeutic applications, and development pathways for next-generation therapies.